Strategic angle: Sen. Ron Johnson raises concerns about the FDA's handling of treatments for rare diseases after discussions with Commissioner Marty Makary.
Strategic angle: Brazilian researchers have developed an index to measure mangrove soil health, showing restored areas can achieve near full functionality.
Strategic angle: A coalition of Kennedy's allies gathered to discuss vaccines, but the health secretary was rarely mentioned.
Ugur Sahin and Özlem Türeci, the couple who co-founded BioNTech, are leaving the Covid-19 vaccine maker to start a new, mRNA-focused firm.
Strategic angle: Epilepsy med response, a long-awaited fix to the kidney transplant system, and more health news
Strategic angle: A look into the financial interests behind the ongoing conflict and its implications.
Strategic angle: A significant change in the eGFR algorithm led to increased kidney transplant opportunities for Black patients.
Strategic angle: Gary Woodland reveals his struggle with post-traumatic stress disorder following brain surgery.
Strategic angle: An international team of researchers has modified a probiotic yeast to enhance safety for vulnerable populations.
Strategic angle: Vertex reported that its drug, acquired for $4.9 billion, halved a key marker of IgA nephropathy in late-stage trials.
Strategic angle: Two individuals arrested for carrying explosives at a protest in New York City reportedly cited the Islamic State as their motivation.
Strategic angle: A groundbreaking approach using CRISPR technology shows promise in treating heart failure by enhancing mitochondrial function.
Strategic angle: Researchers discover new functions of the cereblon protein that could enhance cancer drug efficacy.
Strategic angle: Research reveals how SYFO2 protein facilitates self-fertilization in legumes, enhancing agricultural efficiency.
Strategic angle: Want to make real money just by clicking on virtual trees? Starting today, residents of the United States can begin an online hunt for golden apples.
Strategic angle: A battle between doctors and a hospital system is an early test of a new law designed to separate business and medicine.
Strategic angle: Wall Street's verdict on Prasad, generic semaglutide's new pricing, and other biotech news
Strategic angle: Prasad out again, generic Ozempic on its way, and more health news from Morning Rounds
Strategic angle: Universal Health Services announces acquisition of virtual mental health company Talkspace.
Strategic angle: How a remote patient monitoring company is reworking its tech to enroll in a Medicare program seeking to align payment with health care outcomes.